Cimpress plc filings document the Irish public company's financial reporting, material events, capital structure and shareholder governance. Recent Form 8-K reports furnish quarterly earnings documents for fiscal periods, record material-event disclosures and describe capital-allocation actions such as ordinary share repurchase authorizations.
Proxy filings for Cimpress cover annual general meeting matters, board reappointments, shareholder voting items and governance procedures. The filing record also provides formal disclosure around material agreements, operating and financial results, ordinary-share capital matters and other events relevant to its web-to-print mass-customization business.
Cimpress plc (CMPR) reported that Florian Baumgartner, EVP and CEO, Vista, had 1,025 restricted share units automatically vest on October 15, 2026, and acquired 1,025 ordinary shares. Each RSU represents Cimpress’ commitment to issue one ordinary share. The report also lists 487 ordinary shares delivered or withheld for payment of exercise price or tax liability, with a reported price of $73.44 per share. The reported post-transaction position in the RSU derivative security was 1,026.
CIMPRESS plc (CMPR) reported that CEO and Chairman Robert S. Keane sold a total of 28,000 Ordinary Shares on September 11, 2026, in open-market transactions. The sales included 12,000 shares held directly and 16,000 shares held indirectly through Second Delaware 2003, LLC, at weighted-average prices between about $84.17 and $86.22 per share. After these transactions, Keane continues to hold substantial indirect positions in CIMPRESS through several entities, including 986,785 shares held by Third Delaware 2011, LLC and additional blocks ranging from 28,375 to 51,900 shares in other LLCs and a trust.
CIMPRESS plc (CMPR) received a notice that Robert Keane plans to sell up to 28,000 shares of common stock under Rule 144 through Goldman Sachs & Co. LLC. These shares, with an aggregate market value of $2,373,560, represent part of previously granted restricted stock units used as compensation. As of this notice dated September 11, 2026, there were 24,349,476 CMPR shares outstanding. A prior sale of 6,500 shares for $624,252.98 occurred on August 11, 2026 by Robert & Heather Keane JTWROS. The planned 28,000-share sale is allocated as 12,000 shares by Robert & Heather Keane JTWROS and 16,000 shares by Second Delaware 2003 LLC.
CIMPRESS plc (CMPR) received an Amendment No. 4 to a Schedule 13D from Spruce House-affiliated entities updating their ownership of Cimpress ordinary shares. The Spruce House Partnership LLC holds 1,022,633 shares, which is reported as approximately 4.2% of Cimpress’s 24,349,476 shares outstanding as of August 3, 2026.
Including their direct holdings, Zachary Sternberg and Benjamin Stein each report beneficial ownership of about 4.3% of the outstanding shares. The reporting persons state that, as a result of recent transactions, they ceased to be beneficial owners of more than five percent of Cimpress’s shares on August 18, 2026.
CIMPRESS plc (CMPR) reported that CEO and Chairman Robert S. Keane exercised performance share units into ordinary shares on August 15, 2026. A total of 44,614 ordinary shares were acquired at a conversion price of $0.00 per share upon vesting of multiple performance share unit awards. In a related transaction, 17,624 ordinary shares at $94.46 per share were delivered or withheld for payment of exercise price or tax liability. The filing also lists indirect holdings of ordinary shares through several entities, including RHS Delaware Holdings LLC, Eastern Irrevocable, LLC, Western Irrevocable, LLC, and others.
CIMPRESS plc (CMPR) reported that EVP and Chief Financial Officer Sean Edward Quinn exercised equity awards on August 15, 2026. Restricted share units and performance share units covering 23,319 ordinary shares were converted into ordinary shares at a $0.00 exercise price. In a related transaction, 11,277 ordinary shares were delivered or withheld at $94.46 per share for payment of exercise price or tax liability.
CIMPRESS plc (CMPR) reported insider equity transactions by EVP & Chief Technology Officer Maarten Wensveen. On 2026-08-15, he exercised derivative awards covering 18,543 ordinary shares in total, consisting of restricted share units and performance share units that vested pursuant to prior awards. In connection with these exercises, 8,968 ordinary shares were delivered or withheld at $94.46 per share for payment of exercise price or tax liability. Resulting ordinary-share holdings after these transactions are not stated.
CIMPRESS plc (CMPR) reported insider equity award activity by Florian Baumgartner, EVP and CEO of Vista. On 2026-08-15 he exercised or converted restricted share units and performance share units covering 18,354 Ordinary Shares at a conversion price of $0.00 per share, receiving the underlying shares. On the same date, 8,716 Ordinary Shares at $94.46 per share were delivered or withheld to satisfy payment of exercise price or tax liability, resulting in both acquisitions and dispositions but no net open-market buying or selling.
Cimpress plc director and CEO Robert S. Keane reported open‑market sales of a total of 6,500 Ordinary Shares on August 11, 2026, at per‑share prices including $95.33, $96.50 and $97.06. Footnotes state that the first two trades reflect weighted‑average sale prices over price ranges of $95.00–$95.99 and $96.00–$96.91, respectively. Keane continues to report substantial indirect holdings of Cimpress Ordinary Shares through entities such as RHS Delaware Holdings LLC (28,375 shares, owned by Eastern Irrevocable, LLC and Western Irrevocable, LLC), Second Delaware 2003, LLC (780,000 shares) and Third Delaware 2011, LLC (986,785 shares).